Abstract:Aims/Purpose: Microglia‐mediated neuroinflammation is involved in many neurodegenerative diseases, including glaucoma and diabetic retinopathy. This study examined the effects of anti‐cytokine antibodies on LPS‐induced inflammatory response of microglial cells, and explored the underlying molecular mechanisms by proteomic analysis. Methods: A lipopolysaccharide (LPS)‐induced neuroinflammation model was established in murine BV‐2 microglial cells in vitro. The expression of microglial cell markers (CD68 and CD206) were detected by immunocytochemistry. BV‐2 was stimulated with LPS (1 μg/mL) with or without anti‐tumour necrosis factor‐alpha (anti‐TNF‐α, 2 μg /ml) or anti‐interleukin‐1 beta (anti‐IL‐1β, 4 μg /ml) for 24 h. LPS‐induced inflammation level was analysed using the Griess assay to determine nitric oxide (NO) concentration. Proteome alterations were characterized employing the mass spectrometry‐based proteomics and bioinformatics analyses. Results: Immunocytochemistry confirmed the expression of microglial markers in BV‐2 cells. LPS stimulation induced excessive activation of BV‐2, with significant increase in NO generation ( p < 0.0001). Anti‐IL‐1β significantly attenuated 34% of the LPS‐induced NO generation ( p < 0.0001). Interestingly, anti‐TNF‐α showed a stronger anti‐inflammatory effect by reducing 57% of LPS‐induced NO generation ( p < 0.0001). Bioinformatics analyses revealed that differentially expressed proteins involved in inflammation ( p = 3.8 × 10 −5 ) and apoptotic ( p = 3.2 × 10 −11 ) signalling pathways were significantly activated by LPS. Particularly, LPS‐mediated upregulation of STAT1 ( p = 8.6 × 10 −6 ) was restored by anti‐IL‐1β and anti‐TNF‐α ( p = 3.1 × 10 −4 and p = 2.7 × 10 −3 , respectively). Anti‐IL‐1β induced proteome alterations involved in anti‐inflammatory signalling pathways and promote glial cell polarization towards neuroprotective M2 phenotype ( p = 5.3 × 10 −6 ), while anti‐TNF‐α treatment significantly regulated proteins involved in immune response of macrophages ( p = 2.7 × 10 −8 ). Conclusions: In summary, anti‐TNF‐α and anti‐IL‐1β antibodies alleviated LPS‐induced neuroinflammation and altered proteins involved in neuroprotective pathways. Hence, anti‐cytokine antibodies have therapeutic potential as neuroprotective agents.

1,2,3,4,6 Penta‐O‐Galloyl‐β‐D‐Glucose attenuates LPS/IFNγ‐induced MCP‐5 and Pro‐MMP‐9 Cytokines Release in BV‐2 Microglia Cells by Inhibiting NFkB and MAPK Signaling Proteins

The attenuating effects of 1,2,3,4,6 Penta‐o‐Galloyl‐β‐D‐Glucose on the inflammatory cytokines release from activated BV‐2 microglial cells

Gambogic Acid Inhibits LPS-induced Macrophage Pro-Inflammatory Cytokine Production Mainly Through Suppression of the P38 Pathway

Molecular Mechanisms of the Anti-Inflammatory Effects of Epigallocatechin 3-Gallate (EGCG) in LPS-Activated BV-2 Microglia Cells

Anti-Neuroinflammatory Effects of Ginkgo biloba Extract EGb 761 in LPS-Activated BV2 Microglial Cells

Pentagalloyl glucose induces anti-inflammatory macrophage polarization - suppressing macrophage mediated vascular cell dysfunction and TGF-β secretion

Polysaccharides from Ganoderma lucidum attenuate microglia-mediated neuroinflammation and modulate microglial phagocytosis and behavioural response

Expression of TNF- and IL- can be suppressed via the PPAR-/mTOR signaling pathway in BV-2 microglia: A potential anti-inflammation mechanism

Bacterial peptidoglycan signalling in microglia: Activation by MDP via the NF-κB/MAPK pathway

Expression of TNF‐α and IL‐β can be suppressed via the PPAR‐γ/mTOR signaling pathway in BV‐2 microglia: A potential anti‐inflammation mechanism

Potential neuroprotective effects of anti‐cytokine antibodies against lipopolysaccharide‐induced microglial inflammation

PPAR-gamma agonists as regulators of microglial activation and brain inflammation

Pyrroloquinoline Quinone (Pqq) Inhibits Lipopolysaccharide Induced Inflammation In Part Via Downregulated Nf-Kappa B And P38/Jnk Activation In Microglial And Attenuates Microglia Activation In Lipopolysaccharide Treatment Mice

Immunomodulatory effect of pentagalloyl glucose in LPS-stimulated RAW264.7 macrophages and PAO1-induced Caenorhabditis elegans

Activation of EP2 receptor suppresses poly(I: C) and LPS‐mediated inflammation in primary microglia and organotypic hippocampal slice cultures: Contributing role for MAPKs

MiR-146b-5p/TRAF6 axis is essential for Ginkgo biloba L. extract GBE to attenuate LPS-induced neuroinflammation

Dihydromyricetin attenuates inflammation through TLR4/NF-kappaB pathway

A mixture of extracts from natural ingredients reduces the neurotoxic polarization of microglia via modulating NF-κB/NF-E2-related factor 2 activation

Gastrodin Attenuates Lipopolysaccharide-Induced Inflammatory Response and Migration via the Notch-1 Signaling Pathway in Activated Microglia

Ginkgolide B inhibits NLRP3 inflammasome activation and promotes microglial M2 polarization in Aβ1-42-induced microglia cells

Natural bear bile powder suppresses neuroinflammation in lipopolysaccharide-treated mice via regulating TGR5/AKT/NF-κB signaling pathway